ART use and associated factors among HIV positive caregivers of orphans and vulnerable children in Tanzania.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
17 Aug 2020
Historique:
received: 21 02 2020
accepted: 09 08 2020
entrez: 19 8 2020
pubmed: 19 8 2020
medline: 15 12 2020
Statut: epublish

Résumé

Utilization of antiretroviral therapy (ART) is crucial for better health outcomes among people living with the human immunodeficiency virus (PLHIV). Nearly 30% of the 1.6 million PLHIV in Tanzania are not on treatment. Since HIV positive status is the only eligibility criterion for ART use, it is critical to understand the obstacles to ART access and uptake to reach universal coverage of ART among PLHIV. For the caregivers of orphans and vulnerable children (OVC) LHIV and not on ART, attempts to identify them and ensure that they initiate and continue using ART is critical for their wellbeing and their ability to care for their children. Data are from the community-based, United States Agency for International Development (USAID)-funded Kizazi Kipya project that aims at scaling up the uptake of HIV/AIDS and other health and social services by orphans and vulnerable children (OVC) and their caregivers. HIV positive caregivers of OVC who were enrolled in the USAID Kizazi Kipya project between January 2017 and June 2018 were included in this cross-sectional study. The caregivers were drawn from 11 regions: Arusha, Iringa, Katavi, Kigoma, Mara, Mbeya, Morogoro, Ruvuma, Simiyu, Singida, and Tanga. The outcome variable was ART status (either using or not), which was enquired of each OVC caregiver LHIV at enrollment. Data analysis involved multivariable analysis using random-effects logistic regression to identify correlates of ART use. In total, 74,999 caregivers living with HIV with mean age of 44.4 years were analyzed. Of these, 96.4% were currently on ART at enrollment. In the multivariable analysis, ART use was 30% lower in urban than in rural areas (adjusted odds ratio (OR) = 0.70, 95% confidence interval (CI) 0.61-0.81). Food security improved the odds of being on ART (OR = 1.29, 95% CI 1.15-1.45). Disabled caregivers were 42% less likely than non-disabled ones to be on ART (OR = 0.58, 95% CI 0.45-0.76). Male caregivers with health insurance were 43% more likely than uninsured male caregivers to be on ART (OR = 1.43, 95% CI 1.11-1.83). Caregivers aged 40-49 years had 18% higher likelihood of being on ART than the youngest ones. Primary education level was associated with 26% increased odds of being on ART than no education (OR = 1.26, 95% CI 1.13-1.41). Although nearly all the caregivers LHIV in the current study were on ART (96.4%), more efforts are needed to achieve universal coverage. The unreached segments of the population LHIV, even if small, may lead to worse health outcomes, and also spur further spread of the HIV epidemic due to unachieved viral suppression. Targeting caregivers in urban areas, food insecure households, who are uninsured, and those with mental or physical disability can improve ART coverage among caregivers LHIV.

Sections du résumé

BACKGROUND BACKGROUND
Utilization of antiretroviral therapy (ART) is crucial for better health outcomes among people living with the human immunodeficiency virus (PLHIV). Nearly 30% of the 1.6 million PLHIV in Tanzania are not on treatment. Since HIV positive status is the only eligibility criterion for ART use, it is critical to understand the obstacles to ART access and uptake to reach universal coverage of ART among PLHIV. For the caregivers of orphans and vulnerable children (OVC) LHIV and not on ART, attempts to identify them and ensure that they initiate and continue using ART is critical for their wellbeing and their ability to care for their children.
METHODS METHODS
Data are from the community-based, United States Agency for International Development (USAID)-funded Kizazi Kipya project that aims at scaling up the uptake of HIV/AIDS and other health and social services by orphans and vulnerable children (OVC) and their caregivers. HIV positive caregivers of OVC who were enrolled in the USAID Kizazi Kipya project between January 2017 and June 2018 were included in this cross-sectional study. The caregivers were drawn from 11 regions: Arusha, Iringa, Katavi, Kigoma, Mara, Mbeya, Morogoro, Ruvuma, Simiyu, Singida, and Tanga. The outcome variable was ART status (either using or not), which was enquired of each OVC caregiver LHIV at enrollment. Data analysis involved multivariable analysis using random-effects logistic regression to identify correlates of ART use.
RESULTS RESULTS
In total, 74,999 caregivers living with HIV with mean age of 44.4 years were analyzed. Of these, 96.4% were currently on ART at enrollment. In the multivariable analysis, ART use was 30% lower in urban than in rural areas (adjusted odds ratio (OR) = 0.70, 95% confidence interval (CI) 0.61-0.81). Food security improved the odds of being on ART (OR = 1.29, 95% CI 1.15-1.45). Disabled caregivers were 42% less likely than non-disabled ones to be on ART (OR = 0.58, 95% CI 0.45-0.76). Male caregivers with health insurance were 43% more likely than uninsured male caregivers to be on ART (OR = 1.43, 95% CI 1.11-1.83). Caregivers aged 40-49 years had 18% higher likelihood of being on ART than the youngest ones. Primary education level was associated with 26% increased odds of being on ART than no education (OR = 1.26, 95% CI 1.13-1.41).
CONCLUSIONS CONCLUSIONS
Although nearly all the caregivers LHIV in the current study were on ART (96.4%), more efforts are needed to achieve universal coverage. The unreached segments of the population LHIV, even if small, may lead to worse health outcomes, and also spur further spread of the HIV epidemic due to unachieved viral suppression. Targeting caregivers in urban areas, food insecure households, who are uninsured, and those with mental or physical disability can improve ART coverage among caregivers LHIV.

Identifiants

pubmed: 32807138
doi: 10.1186/s12889-020-09361-6
pii: 10.1186/s12889-020-09361-6
pmc: PMC7433360
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1251

Subventions

Organisme : USAID
ID : 621-A-16-00001

Références

Lancet Glob Health. 2014 Apr;2(4):e209-15
pubmed: 24782953
J Trop Med. 2017;2017:8486451
pubmed: 28567060
Nagoya J Med Sci. 2015 Feb;77(1-2):29-39
pubmed: 25797968
PLoS One. 2014 Aug 13;9(8):e104961
pubmed: 25119665
J Virus Erad. 2016 Oct 5;2(4):227-231
pubmed: 27781105
PLoS One. 2019 Feb 13;14(2):e0211619
pubmed: 30759138
Soc Sci Med. 2018 Feb;198:175-184
pubmed: 29425905
Health Policy Plan. 2012 Mar;27(2):156-65
pubmed: 21414993
J Trop Med. 2019 Apr 7;2019:5165313
pubmed: 31080478
Curr HIV/AIDS Rep. 2018 Apr;15(2):136-146
pubmed: 29504062
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):e52-9
pubmed: 22217680
AIDS Patient Care STDS. 2009 Oct;23(10):867-75
pubmed: 19803678
AIDS Care. 2017 Oct;29(10):1218-1226
pubmed: 28472896
J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):418-25
pubmed: 17099313
S Afr Med J. 2019 Aug 28;109(9):679-685
pubmed: 31635594
J Int AIDS Soc. 2016 Apr 22;19(1):20637
pubmed: 27113335
Front Immunol. 2018 Jun 04;9:1208
pubmed: 29915581
Gastroenterol Hepatol Bed Bench. 2012 Spring;5(2):79-83
pubmed: 24834204
AIDS Care. 2014;26(10):1258-62
pubmed: 24666201
Afr J AIDS Res. 2009 Jun;8(2):123-33
pubmed: 25875564
PLoS One. 2012;7(7):e41998
pubmed: 22860043
Soc Sci Med. 2018 Sep;213:72-84
pubmed: 30059900
AIDS Care. 2018 Jun;30(6):701-705
pubmed: 29058461
AIDS Patient Care STDS. 2006 Sep;20(9):649-57
pubmed: 16987051
AIDS Care. 2007 Mar;19(3):337-45
pubmed: 17453567
Occup Environ Med. 2005 Jul;62(7):500-6, 472
pubmed: 15961628
J Int AIDS Soc. 2019 Apr;22(4):e25272
pubmed: 30983148
AIDS Care. 2014;26(7):907-13
pubmed: 24279762
AIDS Care. 2011 Jun;23(6):764-70
pubmed: 21293989
Pediatr Rev. 2010 Mar;31(3):124-6
pubmed: 20194904
AIDS Behav. 2011 Oct;15(7):1465-74
pubmed: 20352319
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Biomed Res Int. 2018 Mar 21;2018:9619684
pubmed: 29750175
J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):163-70
pubmed: 18769353
Am J Public Health. 2006 Aug;96(8):1429-35
pubmed: 16809585
Vulnerable Child Youth Stud. 2010 Dec 1;5(4):344-352
pubmed: 21165153
Int J Equity Health. 2014 Aug 01;13:60
pubmed: 25078612
BMC Public Health. 2018 Mar 2;18(1):303
pubmed: 29499668
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
Int J Equity Health. 2014 Mar 19;13:25
pubmed: 24645876
PLoS One. 2012;7(6):e38109
pubmed: 22719867
Trop Med Int Health. 2008 Jul;13(7):904-13
pubmed: 18466183
AIDS. 2012 Oct 23;26(16):2059-67
pubmed: 22781227
Biomed Res Int. 2013;2013:470245
pubmed: 24058908
J Int AIDS Soc. 2010 Mar 06;13:8
pubmed: 20205930
J Virus Erad. 2018 Nov 15;4(Suppl 2):16-25
pubmed: 30515310
Clin Epidemiol. 2017 Mar 31;9:195-204
pubmed: 28408854
Health Policy Plan. 2006 Nov;21(6):459-68
pubmed: 17030551
AIDS Care. 2011 Aug;23(8):971-9
pubmed: 21400307

Auteurs

Amon Exavery (A)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania. aexavery@pactworld.org.

John Charles (J)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Asheri Barankena (A)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Erica Kuhlik (E)

Pact, Inc., 1828 L St NW Suite 300, Washington, DC, 20036, USA.

Godfrey M Mubyazi (GM)

National Institute for Medical Research (NIMR), P.O Box 9653, Dar es Salaam, Tanzania.

Kassimu Tani (K)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Amal Ally (A)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Epifania Minja (E)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Alison Koler (A)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Levina Kikoyo (L)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Elizabeth Jere (E)

Pact, P.O. Box 6348, Dar es Salaam, Tanzania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH